Evidence map›Paper›PMID 41060077›Full record

ArticleJMIR research protocols2025

Implementation Mapping to Identify Best Practices for Implementing Population-Wide Genomic Screening Programs: Protocol for the FOCUS (Facilitating the Implementation of Population-Wide Genomic Screening) Study.

Megan Roberts, Jarrod Marable, Kimberly Foss, Cason Whitcomb, Deborah Cragun, Adam Buchanan, Miranda Hallquist, Nathaniel Baker, Rebecca Bosch, Derek W Craig and 4 more

Abstract read
In one paragraph

Article in JMIR research protocols, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Megan RobertsUniversity of North Carolina Hospitals, Chapel Hill, NC, United States.ORCID 0000-0003-3434-2773
Jarrod MarableDepartment of Implementation, Wake Forest University School of Medicine, 525 Vine Street, Winston-Salem, NC, 27101, United States.ORCID 0009-0003-4343-401X
Kimberly FossUniversity of North Carolina Hospitals, Chapel Hill, NC, United States.ORCID 0000-0003-3996-7895
Cason WhitcombUniversity of North Carolina Hospitals, Chapel Hill, NC, United States.ORCID 0000-0002-5234-8178
Deborah CragunUniversity of South Florida, Tampa, FL, United States.ORCID 0000-0002-3620-2857
Adam BuchananGeisinger Health System, Danville, PA, United States.ORCID 0000-0002-6518-2453
Miranda HallquistGeisinger Health System, Danville, PA, United States.ORCID 0000-0001-8554-2447
Nathaniel BakerDepartment of Public Health Sciences, College of Medicine, Medical University of South Carolina, Charleston, SC, United States.ORCID 0000-0003-3313-1579
Rebecca BoschUniversity of North Carolina Hospitals, Chapel Hill, NC, United States.ORCID 0009-0003-4273-5355
Derek W CraigThe University of Texas Health Science Center at Houston, Houston, TX, United States.ORCID 0000-0003-3589-0755
Ingrid WagnerDepartment of Implementation, Wake Forest University School of Medicine, 525 Vine Street, Winston-Salem, NC, 27101, United States.ORCID 0009-0008-8334-6192
Maria FernandezThe University of Texas Health Science Center at Houston, Houston, TX, United States.ORCID 0000-0002-7979-7379
Chanita Hughes-HalbertUniversity of Southern California, Los Angeles, CA, United States.ORCID 0000-0002-0103-6916
Caitlin AllenDepartment of Implementation, Wake Forest University School of Medicine, 525 Vine Street, Winston-Salem, NC, 27101, United States.ORCID 0000-0002-6288-3529

Funding

Facilitating the Implementation of Population-wide Genomic Screening (FOCUS)R01HG013851 · NHGRI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI Caitlin Gloeckner Allen, Megan C. Roberts · 2024 to 2026
$2.2M
NHGRI NIH HHS R01 HG013851
6 · The paper itself

Abstract

Background: Population-wide genomic screening (PGS) for genetic conditions such as hereditary breast and ovarian cancer syndrome, Lynch syndrome, and familial hypercholesterolemia presents opportunities to reduce morbidity and mortality among the 1%-2% of the population at elevated risk for these serious, preventable diseases. With decreasing sequencing costs and growing support from national bodies, there are increasing numbers of PGS programs in the United States. However, guidelines and strategies to support implementation are limited, especially regarding equitable access to PGS. Contextual factors, such as organizational structures and processes, impact PGS implementation, often failing to benefit underrepresented populations. To address these challenges, we are completing the Facilitating the Implementation of Population-wide Genomic Screening (FOCUS) project, which will develop and test a freely available, web-based implementation toolkit to guide best practices for implementing PGS. Objective: The FOCUS project aims to (1) examine barriers and facilitators of PGS implementation at diverse health systems, (2) develop implementation strategies with input from an advisory panel and package them into the FOCUS toolkit, and (3) evaluate the toolkit's impact on improving PGS reach, effectiveness, adoption, and maintenance using a hybrid stepped-wedge cluster randomized trial design. Methods: We will complete implementation mapping, guided by the Consolidated Framework for Implementation Research integrated with health equity, and the Reach, Effectiveness, Adoption, Implementation, and Maintenance framework for Health Equity to develop and evaluate an equity-focused PGS implementation toolkit. The study will involve 10 design sites to identify implementation barriers and facilitators and 12 Test Sites to assess the toolkit's effectiveness. Both design and test sites will be representative of the following 4 stages of implementation: exploration or emerging, planning, implementation, and sustainment. Results: The FOCUS project was funded in September 2024 and will conclude in June 2029. The project was funded through the Advancing Genomic Medicine Research Program at the National Human Genome Research Institute (R01HG013851-01). Data collection for aim 1 (qualitative interviews with implementation team members, patients, and laboratory vendors) began January 2024. At the time of reporting, 33 interviews have been completed with implementation team members, 8 with patients, and two with laboratory vendors. Qualitative analyses for aim 1 are underway at the time of reporting. Conclusions: The FOCUS toolkit will establish a standardized approach to scaling PGS programs across diverse populations and settings, ensuring genomics benefits are accessible to all.

Indexed as

Genetic TestingGenomicsFemaleHumansUnited Stateshealth equityimplementation sciencelearning health systempopulation genomic screeningprotocol

Identifiers

PMID41060077
PMCPMC12505404

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.